Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIg in Childhood-Onset Schizophrenia
NCT00001768Phase 3Completed
- Sponsor
- National Institute of Mental Health
- Start
- Oct 1997
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of intravenous immunoglobulin G in schizophrenia (2 arms), sponsored by National Institute of Mental Health. Started Oct 1997; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00001768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001768.